trial

FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

NCTId NCT01376492
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 709 (actual)
Sponsored by Janssen-Cilag Farmaceutica Ltda.
Primary completion 2011-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
709 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2010-11
Primary completion
2011-07
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Functioning assessmentQuality of sleep assessment

Sponsors

Janssen-Cilag Farmaceutica Ltda.Lead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
709
Phase
NA
Primary Completion Date
2011-07
Status
COMPLETED
relationships
The graph out of here
drug
Functioning assessment
drug
Quality of sleep assessment
drug
lead_sponsor
Janssen-Cilag Farmaceutica Ltda.
company
indication
Schizophrenia
indication
Sleep Initiation and Maintenance Disorders
indication
Schizophrenia
indication